The Protective Role of Immunomodulators on Tissue-Type Plasminogen Activator-Induced Hemorrhagic Transformation in Experimental Stroke: A Systematic Review and Meta-Analysis

Background: Recanalization with tissue plasminogen activator (tPA) is the only approved agent available for acute ischemic stroke. But delayed treatment of tPA may lead to lethal intracerebral hemorrhagic transformation (HT). Numerous studies have reported that immunomodulators have good efficacy on...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Yang, Zhu, Yu-Tian, Tong, Hong-Xuan, Han, Jing-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793743/
https://www.ncbi.nlm.nih.gov/pubmed/33424615
http://dx.doi.org/10.3389/fphar.2020.615166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793743/
https://www.ncbi.nlm.nih.gov/pubmed/33424615
http://dx.doi.org/10.3389/fphar.2020.615166

Ejemplares similares